Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Blood

Retrieve available abstracts of 155 articles:
HTML format
Text format



Single Articles


    September 2017
  1. BERTHAUT I, Bachir D, Kotti S, Chalas C, et al
    Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after six months of treatment.
    Blood. 2017 Sep 28. pii: blood-2017-03-771857. doi: 10.1182/blood-2017-03-771857
    PubMed     Text format    


  2. DUBERT M, Elion J, Tolo A, Diallo DA, et al
    Degree of Anemia, Indirect Markers of Hemolysis, and Vascular Complications of Sickle Cell Disease in Africa.
    Blood. 2017 Sep 20. pii: blood-2016-12-755777. doi: 10.1182/blood-2016-12-755777
    PubMed     Text format     Abstract available


  3. KUNG C, Hixon J, Kosinski PA, Cianchetta G, et al
    AG-348 enhances pyruvate kinase activity in red blood cells from patients with pyruvate kinase deficiency.
    Blood. 2017;130:1347-1356.
    PubMed     Text format     Abstract available


  4. NEGORO E, Nagata Y, Clemente MJ, Hosono N, et al
    Origins of myelodysplastic syndromes after aplastic anemia.
    Blood. 2017 Sep 11. pii: blood-2017-02-767731. doi: 10.1182/blood-2017-02-767731
    PubMed     Text format    


  5. CARSON JL, Stanworth SJ
    Anemia and bleeding in thrombocytopenic patients.
    Blood. 2017;130:1178-1179.
    PubMed     Text format    


  6. GANZ T, Jung G, Naeim A, Ginzburg Y, et al
    Immunoassay for human serum erythroferrone.
    Blood. 2017;130:1243-1246.
    PubMed     Text format     Abstract available


    August 2017

  7. Zaimoku Y, Takamatsu H, Hosomichi K, et al. Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood. 2017;129(21):2908-2916.
    Blood. 2017;130:1072.
    PubMed     Text format    


  8. RIO P, Navarro S, Guenechea G, Sanchez-Dominguez R, et al
    Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34+ cells from Fanconi anemia patients.
    Blood. 2017 Aug 11. pii: blood-2017-03-774174. doi: 10.1182/blood-2017-03-774174
    PubMed     Text format     Abstract available


    July 2017
  9. WAGNER-BALLON O, Michel M
    A rare case of autoimmune hemolytic anemia.
    Blood. 2017;130:559.
    PubMed     Text format    


  10. BERENTSEN S, Randen U, Oksman M, Birgens H, et al
    Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.
    Blood. 2017;130:537-541.
    PubMed     Text format     Abstract available


  11. KELLY AM, Garner SF, Foukaneli T, Godec TR, et al
    The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.
    Blood. 2017;130:214-220.
    PubMed     Text format     Abstract available


  12. GORDEUK VR
    Hemochromatosis, iron-loading anemia, and SMAD.
    Blood. 2017;130:6-7.
    PubMed     Text format    


    June 2017
  13. MALCOVATI L, Galli A, Travaglino E, Ambaglio I, et al
    Clinical significance of somatic mutation in unexplained blood cytopenia.
    Blood. 2017;129:3371-3378.
    PubMed     Text format     Abstract available


  14. ULIRSCH JC, Lareau C, Ludwig LS, Mohandas N, et al
    Confounding in ex vivo models of Diamond-Blackfan anemia.
    Blood. 2017 Jun 14. pii: blood-2017-05-783191. doi: 10.1182/blood-2017-05-783191
    PubMed     Text format    


  15. SIWAPONANAN P, Siegers JY, Ghazali R, Ng T, et al
    Reduced PU.1 expression underlies aberrant neutrophil maturation and function in beta-thalassemia mice and patients.
    Blood. 2017;129:3087-3099.
    PubMed     Text format     Abstract available


  16. CHATURVEDI S, Bhatnagar P, Bean CJ, Steinberg MH, et al
    Genome-wide association study to identify variants associated with vaso-occlusive pain in sickle cell anemia.
    Blood. 2017 Jun 5. pii: blood-2017-02-769661. doi: 10.1182/blood-2017-02-769661.
    PubMed     Text format    


  17. DESAI AA, Lei Z, Bahroos N, Maienschein-Cline M, et al
    Association of circulating transcriptomic profiles with mortality in sickle cell disease.
    Blood. 2017;129:3009-3016.
    PubMed     Text format     Abstract available


  18. E S, Seth A, Vogel P, Sommers M, et al
    Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine beta-thalassemia.
    Blood. 2017;129:3017-3030.
    PubMed     Text format     Abstract available


    May 2017
  19. MASIAS C, Vasu S, Cataland SR
    None of the above: thrombotic microangiopathy beyond TTP and HUS.
    Blood. 2017;129:2857-2863.
    PubMed     Text format     Abstract available


  20. JOKIRANTA TS
    HUS and atypical HUS.
    Blood. 2017;129:2847-2856.
    PubMed     Text format     Abstract available


  21. EATON WA, Bunn HF
    Treating sickle cell disease by targeting HbS polymerization.
    Blood. 2017;129:2719-2726.
    PubMed     Text format     Abstract available


  22. NISS O, Fleck R, Makue F, Alsaied T, et al
    Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia.
    Blood. 2017 May 15. pii: blood-2017-02-767624. doi: 10.1182/blood-2017-02-767624
    PubMed     Text format     Abstract available


  23. FALCON CP, Howard TH
    An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure.
    Blood. 2017;129:2710.
    PubMed     Text format    


  24. GREEN R
    Vitamin B12 deficiency from the perspective of a practicing hematologist.
    Blood. 2017;129:2603-2611.
    PubMed     Text format     Abstract available


  25. KURUVILLA J, Savona M, Baz R, Mau-Sorensen M, et al
    Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin's lymphoma.
    Blood. 2017 May 3. pii: blood-2016-11-750174. doi: 10.1182/blood-2016-11-750174.
    PubMed     Text format     Abstract available


    April 2017
  26. WANG CY, Core AB, Canali S, Zumbrennen-Bullough KB, et al
    Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice.
    Blood. 2017 Apr 24. pii: blood-2016-12-759423. doi: 10.1182/blood-2016-12-759423
    PubMed     Text format     Abstract available


  27. CRISPINO JD, Horwitz MS
    GATA factor mutations in hematologic disease.
    Blood. 2017;129:2103-2110.
    PubMed     Text format     Abstract available


  28. CORAT MA, Schlums H, Wu C, Theorell J, et al
    Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.
    Blood. 2017;129:1940-1946.
    PubMed     Text format     Abstract available


  29. O'BRIEN KA, Farrar JE, Vlachos A, Anderson SM, et al
    Molecular convergence in ex vivo models of Diamond Blackfan anemia.
    Blood. 2017 Apr 4. pii: blood-2017-01-760462. doi: 10.1182/blood-2017-01-760462.
    PubMed     Text format     Abstract available


    March 2017
  30. GO RS, Winters JL, Kay NE
    How I treat autoimmune hemolytic anemia.
    Blood. 2017 Mar 30. pii: blood-2016-11-693689. doi: 10.1182/blood-2016-11-693689
    PubMed     Text format     Abstract available


  31. SONGDEJ D, Babbs C, Higgs DR
    An international registry of survivors with Hb Bart's hydrops fetalis syndrome.
    Blood. 2017;129:1251-1259.
    PubMed     Text format     Abstract available


  32. UEDA Y, Mohammed I, Song D, Gullipalli D, et al
    Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation.
    Blood. 2017;129:1184-1196.
    PubMed     Text format     Abstract available


    February 2017
  33. LI G, Hilliard LM
    Morphologic features of normoblasts in a case of myopathy, lactic acidosis, and sideroblastic anemia.
    Blood. 2017;129:1057.
    PubMed     Text format    


  34. ZAIMOKU Y, Takamatsu H, Hosomichi K, Ozawa T, et al
    Identification of an HLA class I allele closely involved in the auto-antigen presentation in acquired aplastic anemia.
    Blood. 2017 Feb 23. pii: blood-2016-11-752378. doi: 10.1182/blood-2016-11-752378
    PubMed     Text format     Abstract available


  35. HARDER MJ, Kuhn N, Schrezenmeier H, Hochsmann B, et al
    Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.
    Blood. 2017;129:970-980.
    PubMed     Text format     Abstract available


  36. ASSHOFF M, Petzer V, Warr MR, Haschka D, et al
    Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production and ameliorates anemia of chronic disease in rodents.
    Blood. 2017 Feb 10. pii: blood-2016-09-740092. doi: 10.1182/blood-2016-09-740092
    PubMed     Text format     Abstract available


  37. JOSEFSDOTTIR KS, Baldridge MT, Kadmon CS, King KY, et al
    Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.
    Blood. 2017;129:729-739.
    PubMed     Text format     Abstract available


  38. MEHTA PA, Davies SM, Leemhuis T, Myers K, et al
    Radiation-free, alternative donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Blood. 2017 Feb 8. pii: blood-2016-09-743112. doi: 10.1182/blood-2016-09-743112.
    PubMed     Text format     Abstract available


  39. NOY A, de Vos S, Thieblemont C, Martin P, et al
    Targeting BTK with ibrutinib in relapsed/refractory marginal zone lymphoma.
    Blood. 2017 Feb 6. pii: blood-2016-10-747345. doi: 10.1182/blood-2016-10-747345.
    PubMed     Text format     Abstract available


  40. LI H, Choesang T, Bao W, Chen H, et al
    Decreasing TfR1 expression reverses anemia and hepcidin suppression in beta-thalassemic mice.
    Blood. 2017 Feb 1. pii: blood-2016-09-742387. doi: 10.1182/blood-2016-09-742387.
    PubMed     Text format     Abstract available


    January 2017
  41. BACIGALUPO A
    How I treat acquired aplastic anemia.
    Blood. 2017 Jan 17. pii: blood-2016-08-693481. doi: 10.1182/blood-2016-08-693481
    PubMed     Text format     Abstract available


    December 2016
  42. ACHEBE MM, Gafter-Gvili A
    How I treat anemia in pregnancy: iron, cobalamin and folate.
    Blood. 2016 Dec 29. pii: blood-2016-08-672246. doi: 10.1182/blood-2016-08-672246
    PubMed     Text format     Abstract available


  43. HUANG Q
    A striking bone marrow dyserythropoietic change but no anemia.
    Blood. 2016;128:3177.
    PubMed     Text format    


  44. CHANDRAKASAN S, Jayavaradhan R, Ernst J, Shrestha A, et al
    KIT Blockade Is Sufficient for Donor Hematopoietic Stem Cell Engraftment in Fanconi Anemia Mice.
    Blood. 2016 Dec 20. pii: blood-2015-12-689083. doi: 10.1182/blood-2015-12-689083
    PubMed     Text format    


  45. CROSSAN GP
    Metformin: treating the cause of Fanconi anemia?
    Blood. 2016;128:2748-2750.
    PubMed     Text format    


  46. GLUCKMAN E, Cappelli B, Bernaudin F, Labopin M, et al
    Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
    Blood. 2016 Dec 13. pii: blood-2016-10-745711.
    PubMed     Text format     Abstract available


  47. ABAN I, Baddam S, Hilliard LM, Howard TH, et al
    Severe anemia early in life as a risk factor for sickle cell kidney disease.
    Blood. 2016 Dec 5. pii: blood-2016-09-738104.
    PubMed     Text format    


    November 2016
  48. GARGIULO L, Zaimoku Y, Scappini B, Maruyama H, et al
    Glycosylphosphatidylinositol-specific T cells,IFNgamma-producing T cells,and pathogenesis of idiopathic aplastic anemia.
    Blood. 2016 Nov 30. pii: blood-2016-09-740845.
    PubMed     Text format    


  49. LIEM RI, Chan C, Vu TT, Fornage M, et al
    Longitudinal association among sickle cell trait, fitness, and cardiovascular disease risk factors in African Americans in CARDIA.
    Blood. 2016 Nov 16. pii: blood-2016-07-727719.
    PubMed     Text format     Abstract available


  50. MCGANN PT, Hernandez AG, Ware RE
    Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research.
    Blood. 2016 Nov 7. pii: blood-2016-09-702324.
    PubMed     Text format    



  51. Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48(1):63-70.
    Blood. 2016;128:2191.
    PubMed     Text format    


    October 2016
  52. ALJITAWI OS, Paul S, Ganguly A, Lin TL, et al
    Erythropoietin modulation is associated with improved homing and engraftment post umbilical cord blood transplantation.
    Blood. 2016 Oct 19. pii: blood-2016-05-715292.
    PubMed     Text format     Abstract available


  53. ZHANG QS, Tang W, Deater M, Phan N, et al
    Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.
    Blood. 2016 Oct 18. pii: blood-2015-11-683490.
    PubMed     Text format     Abstract available


    September 2016
  54. URRUTIA AA, Afzal A, Nelson J, Davidoff O, et al
    Prolyl-4-hydroxylase 2 and 3 co-regulate murine erythropoietin in brain pericytes.
    Blood. 2016 Sep 28. pii: blood-2016-05-713545.
    PubMed     Text format     Abstract available


    August 2016
  55. RUSSO R, Andolfo I, Manna F, De Rosa G, et al
    Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II.
    Blood. 2016 Aug 18. pii: blood-2016-06-724328.
    PubMed     Text format    


  56. BADE NA, Yared JA
    Unexpected babesiosis in a patient with worsening anemia after allogeneic hematopoietic stem cell transplantation.
    Blood. 2016;128:1019.
    PubMed     Text format    


  57. LICHTENSTEIN DA, Crispin AW, Sendamarai AK, Campagna DR, et al
    A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia.
    Blood. 2016 Aug 3. pii: blood-2016-05-719062.
    PubMed     Text format     Abstract available


    June 2016

  58. MDS and AML in Fanconi anemia.
    Blood. 2016;127:3105.
    PubMed     Text format    


  59. KHAZAL S, Polishchuk V, Manwani D, Gallagher PG, et al
    Allogeneic bone marrow transplantation for treatment of severe hemolytic anemia attributable to hexokinase deficiency.
    Blood. 2016 Jun 13. pii: blood-2016-03-702860.
    PubMed     Text format    


  60. KORDASTI S, Costantini B, Seidl T, Perez Abellan P, et al
    Deep-phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.
    Blood. 2016 Jun 8. pii: blood-2016-03-703702.
    PubMed     Text format     Abstract available


    May 2016

  61. Tanaka KR, Valentine WN, Miwa S. Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia. Blood. 1962;19(3):267-295.
    Blood. 2016;127:2505.
    PubMed     Text format    


  62. BOUTAULT R, Eveillard M
    Acquired elliptocytosis in the setting of a refractory anemia with excess blasts and del(20q).
    Blood. 2016;127:2646.
    PubMed     Text format    



  63. Raab SO, Haut A, Cartwright GE, Wintrobe MM. Pyridoxine-responsive anemia. Blood. 1961;18(3):285-302.
    Blood. 2016;127:2365.
    PubMed     Text format    


  64. BARTNIKAS TB
    Matriptase-2 links erythropoietin to iron.
    Blood. 2016;127:2270-1.
    PubMed     Text format    


    April 2016
  65. OGAWA S
    Clonal hematopoiesis in acquired aplastic anemia.
    Blood. 2016 Apr 27. pii: blood-2016-01-636381.
    PubMed     Text format     Abstract available


  66. PERKINS A, Xu X, Higgs DR, Patrinos GP, et al
    Kruppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.
    Blood. 2016;127:1856-62.
    PubMed     Text format     Abstract available


  67. LU Y, Hanada T, Fujiwara Y, Nwankwo JO, et al
    Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia.
    Blood. 2016 Apr 12. pii: blood-2016-01-692251.
    PubMed     Text format     Abstract available


  68. MCGANN PT
    Hydroxyurea for abnormal TCDs: safe to switch?
    Blood. 2016;127:1738-40.
    PubMed     Text format     Abstract available


    March 2016
  69. PEFFAULT DE LATOUR R, Soulier J
    How we diagnose and treat MDS and AML in Fanconi anemia.
    Blood. 2016 Mar 28. pii: blood-2016-01-583625.
    PubMed     Text format     Abstract available


  70. PINCEZ T, Guitton C, Gauthier F, de Lambert G, et al
    Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study.
    Blood. 2016;127:1616-8.
    PubMed     Text format    



  71. Giblett ER, Coleman DH, Pirzio-Biroli G, Donohue DM, Motulsky AG, Finch CA. Erythrokinetics: quantitative measurements of red cell production and destruction in normal subjects and patients with anemia. Blood. 1956;11(4):291-309.
    Blood. 2016;127:1375.
    PubMed     Text format    


  72. DULMOVITS BM, Appiah-Kubi AO, Papoin J, Hale J, et al
    Pomalidomide reverses gamma-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors.
    Blood. 2016;127:1481-92.
    PubMed     Text format     Abstract available



  73. Rosenthal MC, Pisciotta AV, Komninos ZD, Goldenberg H, Dameshek W. The auto-immune hemolytic anemia of malignant lymphocytic disease. Blood. 1955;10(3):197-227.
    Blood. 2016;127:1217.
    PubMed     Text format    


  74. SPARKENBAUGH EM, Chantrathammachart P, Chandarajoti K, Mackman N, et al
    Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.
    Blood. 2016;127:1371-3.
    PubMed     Text format    


  75. KASSIM AA, Pruthi S, Day M, Rodeghier M, et al
    Silent cerebral infarcts and cerebral aneurysms are prevalent in adults with sickle cell anemia.
    Blood. 2016 Mar 3. pii: blood-2016-01-694562.
    PubMed     Text format    


    February 2016

  76. Dacie JV. Acquired hemolytic anemia: with special reference to the antiglobulin (Coombs') reaction. Blood. 1953;8(9):813-823.
    Blood. 2016;127:955.
    PubMed     Text format    


  77. DUMAS G, Habibi A, Onimus T, Merle JC, et al
    Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.
    Blood. 2016;127:1062-4.
    PubMed     Text format    


  78. LIU D, Yi S, Zhang X, Fang P, et al
    Human STEAP3 mutations with no phenotypic red cell changes.
    Blood. 2016;127:1067-71.
    PubMed     Text format    


  79. BAR C, Povedano JM, Serrano R, Benitez-Buelga C, et al
    Telomerase gene therapy rescues telomere length, bone marrow aplasia and survival in mice with aplastic anemia.
    Blood. 2016 Feb 22. pii: blood-2015-08-667485.
    PubMed     Text format     Abstract available


  80. DUROT E, Patey M
    Pure red cell aplasia revealing nonnodal mantle cell lymphoma.
    Blood. 2016;127:952.
    PubMed     Text format    



  81. Singer K, Fisher B. Studies on abnormal hemoglobins, VI: electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. Blood. 1953;8(3):270-275.
    Blood. 2016;127:791.
    PubMed     Text format    


  82. PARISE LV, Berliner N
    Sickle cell disease: challenges and progress.
    Blood. 2016;127:789.
    PubMed     Text format    


  83. TELEN MJ
    Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.
    Blood. 2016;127:810-9.
    PubMed     Text format     Abstract available


  84. DEBAUN MR, Kirkham FJ
    Central nervous system complications and management in sickle cell disease.
    Blood. 2016;127:829-38.
    PubMed     Text format     Abstract available


  85. HOBAN MD, Orkin SH, Bauer DE
    Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.
    Blood. 2016;127:839-48.
    PubMed     Text format     Abstract available


  86. ZHANG D, Xu C, Manwani D, Frenette PS, et al
    Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.
    Blood. 2016;127:801-9.
    PubMed     Text format     Abstract available


  87. CHESNAIS V, Renneville A, Toma A, Lambert J, et al
    Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.
    Blood. 2016;127:749-60.
    PubMed     Text format     Abstract available


  88. BERNAUDIN F, Verlhac S, Arnaud C, Kamdem A, et al
    Long term follow-up of children with sickle cell anemia treated for abnormal transcranial Doppler velocities.
    Blood. 2016 Feb 5. pii: blood-2015-10-675231.
    PubMed     Text format     Abstract available


    January 2016

  89. Dacie JV. Diagnosis and mechanism of hemolysis in chronic hemolytic anemia with nocturnal hemoglobinuria. Blood. 1949;4(11):1183-1195.
    Blood. 2016;127:371.
    PubMed     Text format    


  90. VINCHI F, Costa da Silva M, Ingoglia G, Petrillo S, et al
    Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
    Blood. 2016;127:473-86.
    PubMed     Text format     Abstract available


  91. THUNG I, Broome HE
    Hemophagocytosis in a patient with sickle cell disease.
    Blood. 2016;127:369.
    PubMed     Text format    


  92. VASANTHAKUMAR A, Arnovitz S, Marquez R, Lepore J, et al
    Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice.
    Blood. 2016;127:310-3.
    PubMed     Text format     Abstract available


  93. GORDEUK VR, Castro OL, Machado R
    Pathophysiology and treatment of pulmonary hypertension in sickle cell disease.
    Blood. 2016 Jan 12. pii: blood-2015-08-618561.
    PubMed     Text format     Abstract available


  94. NAI A, Rubio A, Campanella A, Gourbeyre O, et al
    Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
    Blood. 2016 Jan 11. pii: blood-2015-11-681494.
    PubMed     Text format     Abstract available


    November 2015
  95. BARAZIA A, Li J, Kim K, Shabrani N, et al
    Hydroxyurea with AKT2 inhibition decreases vaso-occlusive events in sickle cell disease mice.
    Blood. 2015;126:2511-7.
    PubMed     Text format     Abstract available


  96. MALINOWSKI AK, Shehata N, D'Souza R, Kuo KH, et al
    Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis.
    Blood. 2015;126:2424-35.
    PubMed     Text format     Abstract available


  97. BRODSKY RA
    Complement in hemolytic anemia.
    Blood. 2015 Nov 18. pii: blood-2015-06-640995.
    PubMed     Text format     Abstract available


  98. DALLE CARBONARE L, Matte' A, Valenti MT, Siciliano A, et al
    Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease.
    Blood. 2015;126:2320-8.
    PubMed     Text format     Abstract available


  99. GORDEUK VR
    Osteoclast activation and sickle bone disease.
    Blood. 2015;126:2259-60.
    PubMed     Text format    


    October 2015
  100. CONWAY EM
    HUS and the case for complement.
    Blood. 2015;126:2085-90.
    PubMed     Text format     Abstract available


  101. SCHRIER SL
    So you know how to treat iron deficiency anemia.
    Blood. 2015;126:1971.
    PubMed     Text format    


  102. DANESHBOD Y, Kazemi T
    Nodal extramedullary hematopoiesis and facial bone change in thalassemia.
    Blood. 2015;126:2070.
    PubMed     Text format    


  103. MOURA IC, Hermine O
    Erythroferrone: the missing link in beta-thalassemia?
    Blood. 2015;126:1974-5.
    PubMed     Text format     Abstract available


  104. KAUTZ L, Jung G, Du X, Gabayan V, et al
    Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia.
    Blood. 2015;126:2031-7.
    PubMed     Text format     Abstract available


  105. SCHMITZ-ABE K, Ciesielski SJ, Schmidt PJ, Campagna DR, et al
    Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9.
    Blood. 2015 Oct 21. pii: blood-2015-09-659854.
    PubMed     Text format     Abstract available


  106. RENNEVILLE A, Van Galen P, Canver MC, McConkey M, et al
    EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.
    Blood. 2015;126:1930-9.
    PubMed     Text format     Abstract available


  107. PAWLINSKI R
    It's "PT" for SCD!
    Blood. 2015;126:1739-40.
    PubMed     Text format     Abstract available


  108. DISCHER DE, Ney PA
    The reason sickle reticulocytes expose PS.
    Blood. 2015;126:1737-8.
    PubMed     Text format     Abstract available


  109. ARUMUGAM PI, Mullins ES, Shanmukhappa SK, Monia BP, et al
    Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.
    Blood. 2015;126:1844-55.
    PubMed     Text format     Abstract available


  110. MANKELOW TJ, Griffiths RE, Trompeter S, Flatt JF, et al
    Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease.
    Blood. 2015;126:1831-4.
    PubMed     Text format     Abstract available


  111. ESTEPP JH
    MAGiC: VOC remains but kids with SCA appear.
    Blood. 2015;126:1637-8.
    PubMed     Text format     Abstract available


  112. BROUSSEAU DC, Scott JP, Badaki-Makun O, Darbari DS, et al
    A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.
    Blood. 2015;126:1651-7.
    PubMed     Text format     Abstract available


    September 2015
  113. GRYGORCZYK R, Mohandas N
    More than one way to shrink.
    Blood. 2015;126:1263-4.
    PubMed     Text format    


  114. GLOGOWSKA E, Lezon-Geyda K, Maksimova Y, Schulz VP, et al
    Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis.
    Blood. 2015;126:1281-4.
    PubMed     Text format     Abstract available


  115. RAPETTI-MAUSS R, Lacoste C, Picard V, Guitton C, et al
    A mutation in the Gardos channel is associated with hereditary xerocytosis.
    Blood. 2015;126:1273-80.
    PubMed     Text format     Abstract available


  116. BELISARIO AR, Sales RR, Toledo NE, Velloso-Rodrigues C, et al
    Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia.
    Blood. 2015;126:1259-60.
    PubMed     Text format    


    August 2015
  117. ROUMENINA LT
    C3dg-CR3 interaction in erythrophagocytosis.
    Blood. 2015;126:828-9.
    PubMed     Text format     Abstract available


  118. LIN Z, Schmidt CQ, Koutsogiannaki S, Ricci P, et al
    Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria.
    Blood. 2015;126:891-4.
    PubMed     Text format     Abstract available


  119. KASSIM AA, Payne AB, Rodeghier M, Macklin EA, et al
    Forced expiratory volume in 1 second is associated with earlier death in sickle cell anemia.
    Blood. 2015 Aug 10. pii: blood-2015-05-644435.
    PubMed     Text format     Abstract available


  120. HRISINKO MA, Chen YH
    Rasburicase-induced Heinz body hemolytic anemia in a patient with chronic lymphocytic leukemia.
    Blood. 2015;126:826.
    PubMed     Text format    


  121. GLADWIN MT
    Revisiting the hyperhemolysis paradigm.
    Blood. 2015;126:695-6.
    PubMed     Text format     Abstract available


  122. DETTERICH JA, Kato RM, Rabai M, Meiselman HJ, et al
    Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
    Blood. 2015;126:703-10.
    PubMed     Text format     Abstract available


  123. ALMEIDA CB, Souza LE, Leonardo FC, Costa FT, et al
    Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Blood. 2015;126:711-20.
    PubMed     Text format     Abstract available


    July 2015
  124. KRIVEGA I, Byrnes C, de Vasconcellos JF, Lee YT, et al
    Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/gamma-globin looping.
    Blood. 2015;126:665-72.
    PubMed     Text format     Abstract available


  125. CUI S, Lim KC, Shi L, Lee M, et al
    The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.
    Blood. 2015;126:386-96.
    PubMed     Text format     Abstract available


  126. RADICH J
    Splicing up the classification of myelodysplasia.
    Blood. 2015;126:128-9.
    PubMed     Text format    


  127. MALCOVATI L, Karimi M, Papaemmanuil E, Ambaglio I, et al
    SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
    Blood. 2015;126:233-41.
    PubMed     Text format     Abstract available


    June 2015
  128. EAR J, Huang H, Wilson T, Tehrani Z, et al
    RAP-011 improves erythropoiesis in zebrafish model of Diamond-Blackfan anemia through antagonizing lefty1.
    Blood. 2015 Jun 24. pii: blood-2015-01-622522.
    PubMed     Text format     Abstract available


  129. KARPONI G, Psatha N, Lederer CW, Adair JE, et al
    Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy.
    Blood. 2015 Jun 18. pii: blood-2015-03-629618.
    PubMed     Text format     Abstract available


  130. MECABO G, Yamamoto M, Biassi TP, Figueiredo MS, et al
    Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: a possible correlation?
    Blood. 2015;125:3821-2.
    PubMed     Text format    


  131. GLUCKMAN E
    Improving survival for Fanconi anemia patients.
    Blood. 2015;125:3676.
    PubMed     Text format    


  132. VERCELLOTTI GM
    Special delivery: microparticles convey heme.
    Blood. 2015;125:3677-8.
    PubMed     Text format     Abstract available


  133. METTANANDA S, Gibbons RJ, Higgs DR
    alpha-Globin as a molecular target in the treatment of beta-thalassemia.
    Blood. 2015;125:3694-701.
    PubMed     Text format     Abstract available


  134. CAMUS SM, De Moraes JA, Bonnin P, Abbyad P, et al
    Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.
    Blood. 2015;125:3805-14.
    PubMed     Text format     Abstract available


  135. STEENSMA DP, Sasu BJ, Sloan JA, Tomita DK, et al
    Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia.
    Blood. 2015;125:3669-71.
    PubMed     Text format    


  136. OKAM MM, Esrick EB, Mandell E, Campigotto F, et al
    Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.
    Blood. 2015;125:3668-9.
    PubMed     Text format    


  137. SADLER JE
    Atypical HUS may become a diagnosis of inclusion.
    Blood. 2015;125:3525-6.
    PubMed     Text format     Abstract available


  138. KUHRT D, Wojchowski DM
    Emerging EPO and EPO receptor regulators and signal transducers.
    Blood. 2015;125:3536-41.
    PubMed     Text format     Abstract available


  139. GAVRIILAKI E, Yuan X, Ye Z, Ambinder AJ, et al
    Modified Ham test for atypical hemolytic uremic syndrome.
    Blood. 2015;125:3637-46.
    PubMed     Text format     Abstract available


  140. ANELE UA, Le BV, Resar LM, Burnett AL, et al
    How I treat priapism.
    Blood. 2015;125:3551-8.
    PubMed     Text format     Abstract available


    May 2015
  141. FRAIMAN YS, Moliterno AR
    High-density genomic analysis reveals basis of spherocytosis in myelodysplastic syndrome.
    Blood. 2015;125:3517.
    PubMed     Text format    


  142. KASSIM AA, Galadanci NA, Pruthi S, DeBaun MR, et al
    How I treat and manage strokes in sickle cell disease.
    Blood. 2015;125:3401-10.
    PubMed     Text format     Abstract available


  143. DE MONTALEMBERT M, Deneux-Tharaux C
    Pregnancy in sickle cell disease is at very high risk.
    Blood. 2015;125:3216-7.
    PubMed     Text format    


  144. COFIELL R, Kukreja A, Bedard K, Yan Y, et al
    Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.
    Blood. 2015;125:3253-62.
    PubMed     Text format     Abstract available


  145. OTENG-NTIM E, Meeks D, Seed PT, Webster L, et al
    Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.
    Blood. 2015;125:3316-25.
    PubMed     Text format     Abstract available


    April 2015
  146. TOLAR J
    Sickle cell and silent spleen.
    Blood. 2015;125:2589-90.
    PubMed     Text format     Abstract available


  147. TELEN MJ, Wun T, McCavit TL, De Castro LM, et al
    Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
    Blood. 2015;125:2656-64.
    PubMed     Text format     Abstract available


  148. HOBAN MD, Cost GJ, Mendel MC, Romero Z, et al
    Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.
    Blood. 2015;125:2597-604.
    PubMed     Text format     Abstract available


  149. ANDERSEN GR
    Mutations in complement C3 from aHUS patients.
    Blood. 2015;125:2316-8.
    PubMed     Text format     Abstract available


  150. MAGOR GW, Tallack MR, Gillinder KR, Bell CC, et al
    KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.
    Blood. 2015;125:2405-17.
    PubMed     Text format     Abstract available


  151. SCHRAMM EC, Roumenina LT, Rybkine T, Chauvet S, et al
    Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.
    Blood. 2015;125:2359-69.
    PubMed     Text format     Abstract available


    March 2015
  152. SIEGEMUND S, Rigaud S, Conche C, Broaten B, et al
    IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice.
    Blood. 2015 Mar 18. pii: blood-2014-06-583187.
    PubMed     Text format     Abstract available


  153. PAESSLER M, Hartung H
    Dehydrated hereditary stomatocytosis masquerading as MDS.
    Blood. 2015;125:1841.
    PubMed     Text format    


  154. XIANG J, Wu DC, Chen Y, Paulson RF, et al
    In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors.
    Blood. 2015;125:1803-12.
    PubMed     Text format     Abstract available


    February 2015
  155. RASHIDI A, Fisher SI
    Unwelcome passengers.
    Blood. 2015;125:1507.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: